Fundraising Fox
Reglagene
Oro Valley, US · Founded 2018 · 2 known investors
Find your way into Reglagene
Sign up to see every warm intro you have to Reglagene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Reglagene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Reglagene develops a brain-penetrant oral drug therapy designed to treat primary tumors and brain metastases in patients with cancer. The company focuses on CNS oncology, targeting a mechanism validated in solid tumors but previously unexploited for brain-penetrant therapies.
Founders & leadership
Reglagene was founded in 2018 by Vijay Gokhale.
Investors · 2
How we know: Cancer Fund's portfolio page · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$5.7M disclosed across 4 rounds · 2018–2024
▶$766.7KraisedMay 2024 · 12 investors · BiotechnologyRule 506(b)
- Richard AustinExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $766.7K
- Minimum investment
- $50K
- First sale
- May 2024
- Incorporated
- Corporation, Arizona, 2024
- Federal exemptions
- 06b
▶$3.8MraisedNov 2023 · 22 investors · BiotechnologyRule 506(b)
- Sharon AydDirector
- Lawrence KinetDirector
- Laurence HurleyDirector
- Richard AustinExecutive Officer, Director
- Offering amount
- $3.8M
- Amount sold
- $3.8M
- Minimum investment
- $25K
- First sale
- Jul 2022
- Incorporated
- Corporation, Arizona, 2018
- Federal exemptions
- 06b
▶$600KraisedJul 2021 · 3 investors · BiotechnologyRule 506(b)
- Sharon AydDirector
- Laurence HurleyDirector
- Lawrence KinetDirector
- Richard AustinExecutive Officer, Director
- David J. BearssDirector
- Offering amount
- $1.5M
- Amount sold
- $600K
- Minimum investment
- $25K
- First sale
- Jul 2021
- Incorporated
- Corporation, Arizona, 2018
- Federal exemptions
- 06b
▶$546.4KraisedAug 2018 · 11 investors · BiotechnologyRule 506(b)
- Richard AustinExecutive Officer, Director
- Laurence HurleyDirector
- Offering amount
- $2M
- Amount sold
- $546.4K
- Minimum investment
- $25K
- First sale
- Jul 2018
- Incorporated
- Corporation, Arizona, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Reglagene do?
- Reglagene develops a brain-penetrant oral drug therapy designed to treat primary tumors and brain metastases in patients with cancer. The company focuses on CNS oncology, targeting a mechanism validated in solid tumors but previously unexploited for brain-penetrant therapies.
- Who founded Reglagene?
- Reglagene was founded by Vijay Gokhale in 2018.
- Who are Reglagene's investors?
- Reglagene's investors include Cancer Fund, Tech Coast Angels.
- How much funding has Reglagene raised?
- Reglagene has disclosed $5.7M raised across 4 rounds.
- Where is Reglagene headquartered?
- Reglagene is headquartered in Oro Valley, US.